Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online January 18, 2007
Stem Cells Vol. 25 No. 5 May 2007, pp. 1096 -1103
doi:10.1634/stemcells.2006-0505; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0505v1
25/5/1096    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liou, J.-Y.
Right arrow Articles by Wu, K. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liou, J.-Y.
Right arrow Articles by Wu, K. K.

EMBRYONIC STEM CELLS: CHARACTERIZATION SERIES

Cyclooxygenase-2-Derived Prostaglandin E2 Protects Mouse Embryonic Stem Cells from Apoptosis

Jun-Yang Lioua,b, David P. Ellenta,b, Sang Leea,b, Jennifer Goldsbya,b,c, Bor-Sheng Koa,b, Nena Matijevica,b, Jaou-Chen Huangc, Kenneth K. Wua,b,d

aDivision of Hematology,
bVascular Biology Research Center, and
cDepartment of Obstetrics and Gynecology, The University of Texas Health Science Center at Houston, Houston, Texas, USA;
dNational Health Research Institutes, Zhunan, Miaoli, Taiwan

Key Words. Mouse embryonic stem cell • Cyclooxygenase-2 • PGE2 • EP2 receptor • Apoptosis • Akt

Correspondence: Kenneth K. Wu, M.D., Ph.D., Division of Hematology and Vascular Biology Research Center, The University of Texas Health Science Center at Houston, 6431 Fannin, MSB 5.016, Houston, Texas 77030, USA. Telephone: 713-500-6801; Fax: 713-500-6812; e-mail: Kenneth.K.Wu{at}uth.tmc.edu

Received August 10, 2006; accepted for publication January 4, 2007.
First published online in STEM CELLS EXPRESS   January 18, 2007.



Little is known about prostaglandin synthesis and function in embryonic stem cells. We postulated that mouse embryonic stem (mES) cells possess enzymes to synthesize protective prostaglandins. Compared with differentiated adult cells, mES cells were less susceptible to H2O2-induced apoptosis. However, their apoptosis was enhanced by indomethacin or SC-236, a selective inhibitor of cyclooxygenase (COX)-2. Analysis of COX pathway enzymes by Western blotting revealed expression of COX-2 and cytosolic and microsomal prostaglandin E2 (PGE2) synthases. COX-1 and prostacyclin (PGI2) synthases were undetectable. mES cells produced PGE2 but not PGI2. Importantly, PGE2 rescued mES cells from apoptosis. To elucidate the signaling mechanism by which PGE2 inhibits apoptosis, we analyzed E-type prostaglandin (EP) receptors by Western blots. All EP isoforms were detected except EP4. Butaprost, a specific EP2 agonist, rescued mES cells from apoptosis, whereas sulprostone, an EP1/EP3 agonist, had no effect, suggesting selective interaction of PGE2 with EP2. The antiapoptotic effect of PGE2 was abrogated by Ly-294002 or wortmannin but not H-89 or a specific inhibitor of protein kinase A, suggesting signaling via phosphatidylinositol-3 kinase (PI-3K). Akt was constitutively active in mES cells, which were inhibited by indomethacin and rescued by PGE2. The rescuing effect of PGE2 was abrogated by Ly-294002. These results indicate that mES cells constitutively express COX-2 and PGE synthases and produce PGE2, which confers resistance to apoptosis via EP2-mediated activation of PI-3K to the Akt pathway.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J.-Y. Liou, C.-C. Wu, B.-R. Chen, L. B. Yen, and K. K. Wu
Nonsteroidal Anti-Inflammatory Drugs Induced Endothelial Apoptosis by Perturbing Peroxisome Proliferator-Activated Receptor-{delta} Transcriptional Pathway
Mol. Pharmacol., November 1, 2008; 74(5): 1399 - 1406.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Fiegl, A. Jones, C. Hauser-Kronberger, G. Hutarew, R. Reitsamer, R. L. Jones, M. Dowsett, E. Mueller-Holzner, G. Windbichler, G. Daxenbichler, et al.
Methylated NEUROD1 Promoter is a Marker for Chemosensitivity in Breast Cancer
Clin. Cancer Res., June 1, 2008; 14(11): 3494 - 3502.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
T. M. Onorato, P. W. Brown, and P. L. Morris
Mono-(2-ethylhexyl) Phthalate Increases Spermatocyte Mitochondrial Peroxiredoxin 3 and Cyclooxygenase 2
J Androl, May 1, 2008; 29(3): 293 - 303.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Elberg, D. Elberg, T. V. Lewis, S. Guruswamy, L. Chen, C. J. Logan, M. D. Chan, and M. A. Turman
EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1622 - F1632.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2007 by AlphaMed Press.